Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by HILMI KODAZ
Comparative Analysis of the Efficacy and Safety of Modified FOLFOX-6 and DCF Regimens as First-Line Treatment in Advanced Gastric Cancer
Molecular and Clinical Oncology
Cancer Research
Oncology
Related publications
Comparison of Short-Term Efficacy and Safety of TIROX and DCF Regimens for Advanced Gastric Cancer
Journal of International Medical Research
Biochemistry
Medicine
Cell Biology
Oxaliplatin, 5-Fluorouracil and Leucovorin (Modified FOLFOX-6) as First-Line Chemotherapy for Advanced Gastric Cancer Patients With Poor Performance Status
Oncology Letters
Cancer Research
Oncology
A Comparative Study of Treatment Toxicities Between FOLFOX 4 and Modified FOLFOX 6 in Iranian Colorectal Cancer Patients
Iranian Journal of Cancer Prevention
Association Between UGT1A1 Gene Polymorphism and Safety and Efficacy of Irinotecan Monotherapy as the Third-Line Treatment for Advanced Gastric Cancer
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
P3.01-94 Safety and Efficacy of First-Line Pemetrexed Versus Bevacizumab-Containing Regimens in Advanced Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
A Phase II Study of Modified FOLFOX as First-Line Chemotherapy for Metastatic Gastric Cancer in Elderly Patients With Associated Diseases
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
Efficacy and Safety of Icotinib as First-Line Therapy in Patients With Advanced Non-Small-Cell Lung Cancer
OncoTargets and Therapy
Oncology
Pharmacology
Effects of Modified FOLFOX-6 Chemotherapy on Cellular Immune Function in Patients With Gastric Cancer
Oncology Letters
Cancer Research
Oncology
Differential Effect of MMSET mRNA Levels on Survival to First-Line FOLFOX and Second-Line Docetaxel in Gastric Cancer
British Journal of Cancer
Cancer Research
Oncology
